Research · Analysis · Intelligence

Insights

Data-driven research on India's pre-IPO market — IPO analysis, company deep dives, and market intelligence. For research purposes only.

Featured

IPO Analysis15 April 2026· 7 min read

NSE IPO 2026: Timeline, Unlisted Share Price, Valuation, and What to Watch

NSE IPO 2026 latest update — DRHP filing expected mid-2026, listing targeted before December. FY25 net profit ₹12,188 Cr, unlisted share price ~₹1,900. Full research summary.

Read full analysis →

All Articles

Company Deep Dive18 April 2026· 6 min read

PharmEasy Restructuring 2026: What Happened, Current Valuation, and What Comes Next

PharmEasy went from a $5.4B IPO filing to a ₹3/share rights issue. A clear-eyed look at the debt restructuring, unlisted valuation reset, and what needs to happen before the story changes.

Read full analysis →

Disclaimer: All articles on this page are for informational and research purposes only. Nothing published here constitutes investment advice, a solicitation to buy or sell securities, or a recommendation of any kind. Unlisted share prices and valuations are indicative and not exchange-regulated. Please consult a SEBI-registered investment advisor before making any investment decisions.